Soon after reports of a novel coronavirus capable of causing severe pneumonia surfaced in
late 2019, expeditious global spread of the Severe Acute Respiratory Distress Syndrome …

Background In the past 20 years four major viral infectious diseases outbreaks caused
hundreds of thousands of deaths worldwide: SARS, Influenza H1N1, MERS, and COVID-19 …

Introduction The increasing evidence of SARS‐CoV‐2 impact on the central nervous system
(CNS) raises key questions on its impact for risk of later life cognitive decline, Alzheimer's …

Brain imaging studies of patients with COVID-19 show evidence of macro-and
microhemorrhagic lesions, multifocal white matter hyperintensities, and lesions consistent …

Neurological features of COVID-19 have been reported in addition to the respiratory
manifestations, but cognitive dysfunction has been scarcely described. And cognitive …

As severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infections have
been shown to affect the central nervous system, the investigation of associated alterations …

Background and objective COVID-19 neurological manifestations have been progressively
recognized. Among available MRI techniques, diffusion weighted imaging (DWI) shows …

Acute delirium and other neuropsychiatric symptoms have frequently been reported in
COVID-19 patients and are variably referred to as acute encephalopathy, COVID-19 …

Aims: In response to the rapid spread of COVID-19, this paper provides health professionals
with better accessibility to available evidence, summarising findings from a systematic …

BACKGROUND: Neurologic events have been reported in patients with coronavirus disease
2019 (COVID-19). However, a model-based evaluation of the spatial distribution of these …